$AMGN · Amgen Inc.
This SEC Form 4 filing reports a change in beneficial ownership for Michael V. Drake, a director of Amgen Inc. On November 6, 2026, Drake acquired 114.0263 shares of Amgen common stock at a price of $0. The shares were received through the vesting of restricted stock units granted under the Amgen Inc. 2009 Director Equity Incentive Program, as amended. These restricted stock units vested immediately and are paid in common stock on a one-to-one basis, though a director may elect to defer payment.
Following the reported transaction, Drake directly held 6,030.1896 shares of Amgen common stock. The filing also notes that this total includes 417 dividend equivalents credited to Drake’s unvested restricted stock units under the company’s equity incentive plan. These dividend equivalents are paid out in shares of common stock on a one-to-one basis according to the vesting schedule, with any remaining fractional share amount paid in cash.